STING Activation in Dendritic Cells Enhances Antigen Presentation by Live Tumor Cells
European Journal of Immunology · 2026-05 · 56 (5)
DOI: 10.1002/eji.70212 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 27.05.2026. Verfasst von Adriana Loverre und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, PSL Research University, INSERM U932, Paris, France. Hauptthemen laut MEDLINE: Dendritic Cells, Antigen Presentation, Membrane Proteins, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer, Fondation pour la Recherche Médicale, Agence Nationale de la Recherche.
Abstract (Originalsprache)
The stimulator of interferon genes (STING) pathway is a key regulator of antitumor immunity. Activation of STING by the natural agonist 2′3′‐cyclic GMP‐AMP (cGAMP) induces type I interferon and promotes CD8 + T cell responses against tumors. However, how type I interferon modulates tumor cell recognition by T cells remains unclear. Here, using a co‐culture model and virus‐like particles encapsulating cGAMP (cGAMP‐VLP), we show that STING activation in dendritic cells enhances CD8 + T cell recognition of live tumor cells through type I interferon signaling. This effect is independent of enhanced cross‐presentation of soluble or tumor‐associated antigens. Instead, type I interferon produced downstream of STING signaling drives MHC‐I upregulation on tumor cells, which is required for T cell activation. In vivo, host STING activation with cGAMP‐VLP improves the efficacy of immune checkpoint blockade, particularly in tumors lacking cGAS. Together, these findings identify a transcellular mechanism whereby STING activation in dendritic cells increases tumor cell MHC‐I expression to enhance CD8 + T cell‐mediated tumor recognition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Curie, PSL Research University, INSERM U932, Paris, France.
- Stimunity, Paris, France.
- Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Förderung
- Ligue Contre le Cancer
- Fondation pour la Recherche Médicale
- Agence Nationale de la Recherche
- Fondation ARC pour la Recherche sur le Cancer
Zitieren
APA
Loverre, A., Jneid, B., Genest, M., van den Broek, M., & Manel, N. (2026). STING Activation in Dendritic Cells Enhances Antigen Presentation by Live Tumor Cells. European Journal of Immunology, 56(5). https://doi.org/10.1002/eji.70212
Vancouver
Loverre A, Jneid B, Genest M, van den Broek M, Manel N. STING Activation in Dendritic Cells Enhances Antigen Presentation by Live Tumor Cells. European Journal of Immunology. 2026;56(5). doi:10.1002/eji.70212
BibTeX
@article{Loverre2026,
author = {Loverre, Adriana and Jneid, Bakhos and Genest, Magali and van den Broek, Maries and Manel, Nicolas},
title = {STING Activation in Dendritic Cells Enhances Antigen Presentation by Live Tumor Cells},
journal = {European Journal of Immunology},
year = {2026},
volume = {56},
number = {5},
doi = {10.1002/eji.70212}
}
EUVIMED